I believe reducing barriers to generic drugs and increasing competition in the pharmaceutical market will benefit American families.
the Energy and Commerce Committee is one of the few--maybe the only one--that has complete, regular order.
I find it immensely troubling that they agency witnesses were not considered by the Democrats.
As Chairman of this Subcommittee, I never would have even thought about holding a hearing on seven bills that were not s...
These numbers alone demonstrate the substantial cost savings for consumers when we ensure generic products can come to m...
These are choices Americans simply should not have to make.
the committee begins the process of fulfilling our commitment to provide some much-needed relief to Americans struggling...
Generic drugs play a critical role in increasing access and reducing costs in our healthcare system.
One way to achieve this goal is to facilitate greater competition from generic and biosimilar manufacturers.
It is unacceptable and could, in fact, lead to greater illness and higher medical costs down the road.
For more than 50 years, communities and millions of individuals across the country have depended on the NFIP to help the...